Relenza, the new flu treatment controversially excluded from the NHS because
a panel decided it was not cost-effective, can cause breathing difficulties in
patients with asthma. Glaxo Wellcome, which makes the drug, warned doctors of
the danger last week. The company says the number of people who have suffered
breathing difficulties after taking the drug is tiny, and that the warning is
simply a precaution. But the news is unfortunate, given that flu patients with
chronic lung disease are among the ones most likely to benefit from effective
influenza treatments.
To continue reading, today with our introductory offers
Advertisement
More from New ¾«¶«´«Ã½
Explore the latest news, articles and features
Popular articles
Trending New ¾«¶«´«Ã½ articles
1
Sperm have been made magnetic to allow IVF inside the body
2
Autism may have two distinct subtypes that vary by brain activity
3
Fully autonomous drones have killed human soldiers for the first time
4
Has the answer to life's origins been hiding in our cells all along?
5
We may have finally solved cosmology's chicken-or-the-egg problem
6
A quantum state that lasts forever may finally be within our grasp
7
Arctic Ocean reaches tipping point that could be dire for marine life
8
Technology is changing our perspective on nature – at every scale
9
Global map reveals the vast scale of underground fungal networks
10
What if the idea of the autism spectrum is completely wrong?
